Furthermore, higher sPD-L1 levels are associated with poorer outcomes and disease-free survival across various cancer types, like NSCLC, melanoma, esophageal, pancreatic, and gastric cancer [5,6,7,15,35,36,37,38] (Table 1). Here, SPDL1 is linked to gastric cancer.